Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
CNY 71.53
(1.26%)
CNY 71.53
(1.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.35 Billion CNY | 33.22% |
| 2022 | 1.76 Billion CNY | 24.18% |
| 2021 | 1.42 Billion CNY | 19.4% |
| 2020 | 1.19 Billion CNY | 51.01% |
| 2019 | 789.82 Million CNY | 11.59% |
| 2018 | 707.76 Million CNY | 11.09% |
| 2017 | 637.12 Million CNY | -0.85% |
| 2016 | 642.58 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.42 Billion CNY | 3.01% |
| 2024 Q2 | 2.4 Billion CNY | -0.91% |
| 2024 Q3 | 2.68 Billion CNY | 11.58% |
| 2023 Q4 | 2.35 Billion CNY | 10.24% |
| 2023 Q3 | 2.13 Billion CNY | 14.67% |
| 2023 Q1 | 1.84 Billion CNY | 4.32% |
| 2023 FY | 2.35 Billion CNY | 33.22% |
| 2023 Q2 | 1.86 Billion CNY | 1.02% |
| 2022 Q2 | 1.53 Billion CNY | 2.88% |
| 2022 Q1 | 1.49 Billion CNY | 4.72% |
| 2022 Q3 | 1.61 Billion CNY | 5.5% |
| 2022 FY | 1.76 Billion CNY | 24.18% |
| 2022 Q4 | 1.76 Billion CNY | 9.26% |
| 2021 Q1 | 1.22 Billion CNY | 2.29% |
| 2021 Q2 | 1.25 Billion CNY | 3.11% |
| 2021 Q4 | 1.42 Billion CNY | 5.73% |
| 2021 Q3 | 1.34 Billion CNY | 7.07% |
| 2021 FY | 1.42 Billion CNY | 19.4% |
| 2020 Q4 | 1.19 Billion CNY | 5.58% |
| 2020 Q1 | 1.13 Billion CNY | 43.63% |
| 2020 FY | 1.19 Billion CNY | 51.01% |
| 2020 Q3 | 1.12 Billion CNY | -0.17% |
| 2020 Q2 | 1.13 Billion CNY | -0.24% |
| 2019 Q3 | 751.41 Million CNY | 4.57% |
| 2019 FY | 789.82 Million CNY | 11.59% |
| 2019 Q4 | 789.82 Million CNY | 5.11% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 718.54 Million CNY | 0.0% |
| 2018 FY | 707.76 Million CNY | 11.09% |
| 2018 Q4 | 707.76 Million CNY | 0.0% |
| 2017 FY | 637.12 Million CNY | -0.85% |
| 2016 FY | 642.58 Million CNY | 0.0% |